Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: APOLLO Trial: Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial